Serene Chambers
2nd Floor Road No. 7 Banjara Hills
Hyderabad 500034
India
91 40 3980 4333
https://www.lauruslabs.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 6,007
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Satyanarayana Chava M.Sc., Ph.D. | CEO & Whole Time Director | 134.71M | N/A | 1961 |
Mr. Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A. | CFO & Whole-Time Director | 43.81M | N/A | 1965 |
Mr. B. V. R. K. Suryadevara Srinivasa Rao | Executive Vice President of Manufacturing & Operations | N/A | N/A | 1968 |
Mr. Martyn Oliver-James Peck | Executive Vice President of Business Development | N/A | N/A | N/A |
Ch. Venkata Ramana Rao | Senior Vice President of Intellectual Property Management | N/A | N/A | 1971 |
Dr. Vasireddi Uma Maheswer Rao | Executive Vice President of Chemical R&D | N/A | N/A | 1961 |
Mr. Thomas Versosky | President of FDF - North America | N/A | N/A | N/A |
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Laurus Labs Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.